UCAAMP hosts lunch focused on innovation
Join UCAAMP for lunch and an innovation panel featuring faculty from the College of Engineering and Applied Science
Event Information (passed)
Join UCAAMP for lunch and an innovation panel featuring faculty from the University of Cincinnati College of Engineering and Applied Science. The panel will include topics on UC innovations in the area of Intelligent Robotics, UAV (unmanned aerial vehicle) research, additive manufacturing, and AI (artificial intelligence) developments. Each presenter will include a brief presentation of their work followed by questions.
Panel Participants:
- Dr. Teri Reed, Executive Director of CEAS
- Dr. Ashley E. Paz y Puente, additive manufacturing
- Dr. Rashmi Jha, neuromorphic “Systems on a Chip” for artificial intelligence and cybersecurity
- Dr. Kelly Cohen, artificial intelligence
- Dr. Marc Cahay, micro- and nano- scale artificial neural networks
- Dr. Manish Kumar, unmanned aerial vehicles
- Dr. Ou Ma, intelligent robotics
Menu:
- Chicken or beef taco salad with assorted toppings
- Mexican rice
- Refried beans
- Cinnamon churros
Tags
Related Stories
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
UC awarded nearly $1 million to help fight infant obesity spike
December 12, 2025
University of Cincinnati researcher Cathy Stough spoke with Spectrum News1 about a nearly $1 million National Institutes of Health grant awarded to UC to help prevent infant obesity through early nutrition support and family-based interventions.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.